The design, synthesis and evaluation of novel HIV-1 protease inhibitors with high potency against PI-resistant viral strains

Bioorganic & Medicinal Chemistry Letters
2003.0

Abstract

Replacement of the pyridylmethyl moiety in indinavir with a pyridyl oxazole yielded HIV-1 protease inhibitors (PI) with greatly improved potency against PI-resistant HIV-1 strains. A meta-methoxy group on the pyridyl ring and a gem-dimethyl methyl linkage afforded compound 10 with notable in vitro antiviral activity against HIV-1 viral strains with reduced susceptibility to the clinically available PIs. Compound 10 also demonstrated favorable in vivo pharmacokinetics in animal models.

Knowledge Graph

Similar Paper

The design, synthesis and evaluation of novel HIV-1 protease inhibitors with high potency against PI-resistant viral strains
Bioorganic & Medicinal Chemistry Letters 2003.0
HIV protease inhibitors with picomolar potency against PI-Resistant HIV-1 by extension of the P3 substituent
Bioorganic & Medicinal Chemistry Letters 2003.0
P1′ oxadiazole protease inhibitors with excellent activity against native and protease inhibitor-resistant HIV-1
Bioorganic & Medicinal Chemistry Letters 2004.0
Novel HIV-1 protease inhibitors active against multiple PI-Resistant viral strains: coadministration with indinavir
Bioorganic & Medicinal Chemistry Letters 2003.0
Synthesis of novel HIV protease inhibitors (PI) with activity against PI-resistant virus
Bioorganic & Medicinal Chemistry Letters 2007.0
HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1′ substituent
Bioorganic & Medicinal Chemistry Letters 2003.0
Synthesis and activity of novel HIV protease inhibitors with improved potency against multiple PI-resistant viral strains
Bioorganic & Medicinal Chemistry Letters 2002.0
Novel inhibitors of HIV protease
Bioorganic & Medicinal Chemistry Letters 2000.0
Indinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-Resistant viral strains
Bioorganic & Medicinal Chemistry Letters 2002.0
Design of HIV-1 Protease Inhibitors with Pyrrolidinones and Oxazolidinones as Novel P1′-Ligands To Enhance Backbone-Binding Interactions with Protease: Synthesis, Biological Evaluation, and Protein−Ligand X-ray Studies
Journal of Medicinal Chemistry 2009.0